Session 3 : HER2 Positive Breast Cancer

HER2 Positive Breast Cancer By TP Sahoo

Chairpersons :

D C Doval, CJ Tamane

Speaker :

TP Sahoo

“ORAL Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2 positive cohort of the Gepar Quinto study (GBG 44)”

Author: M. Untch

Conference: ESMO

Five-year analysis of the phase II NeoSphere trial evaluating four cycles of neoadjuvant docetaxel (D) and/ or trastuzumab (T) and/ or pertuzumab (P)

Author: L. Gianni

Conference: ASCO